Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
14.44
+1.00 (7.44%)
At close: Aug 4, 2025, 4:00 PM
14.39
-0.05 (-0.35%)
After-hours: Aug 4, 2025, 7:41 PM EDT
Denali Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts that cover Denali Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $33.85, which forecasts a 134.42% increase in the stock price over the next year. The lowest target is $24 and the highest is $45.
Price Target: $33.85 (+134.42%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 19, 2025.
Analyst Ratings
The average analyst rating for Denali Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 7 | 7 | 7 |
| Buy | 5 | 7 | 7 | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 16 | 16 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $28 → $27 | Strong Buy | Maintains | $28 → $27 | +86.98% | May 19, 2025 |
| Baird | Baird | Buy Maintains $30 → $29 | Buy | Maintains | $30 → $29 | +100.83% | May 8, 2025 |
| Wedbush | Wedbush | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +107.76% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $32 | Strong Buy | Maintains | $80 → $32 | +121.61% | May 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +93.91% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
23.02M
Revenue Next Year
97.44M
from 23.02M
Increased by 323.34%
EPS This Year
-3.08
from -2.57
EPS Next Year
-2.93
from -3.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | 145.1M | 298.3M | 568.1M | |
| Avg | 23.0M | 97.4M | 251.6M | |
| Low | n/a | 9.4M | 105.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | - | 1,196.2% | 483.0% | |
| Avg | - | 323.3% | 158.2% | |
| Low | - | -59.3% | 7.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | -2.08 | -1.61 | -0.96 | |
| Avg | -3.08 | -2.93 | -2.47 | |
| Low | -3.54 | -3.69 | -3.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.